119 results
Page 5 of 6
8-K
EX-10.3
jcz n84sox8mb
6 Jul 20
Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
10:31am
8-K
EX-99.1
hoy pbbtg79b3l0c72a4
11 May 20
Unum Therapeutics Reports First Quarter Financial Results and Provides Corporate Updates
4:38pm
8-K
EX-99.1
wx4 ghyg5pngur1gl
26 Mar 20
Unum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Updates
7:39am
424B5
s3e zhcqejm9
20 Mar 20
Prospectus supplement for primary offering
8:26am
8-K
EX-99.1
9uau8ic0hu3q8l xzgns
20 Mar 20
Unum Therapeutics Announces Common Stock Purchase Agreement for up to $25
7:40am
8-K
EX-10.1
bedyevlfe
20 Mar 20
Unum Therapeutics Announces Common Stock Purchase Agreement for up to $25
7:40am
8-K
EX-10.2
swmg0k zg1isbdm
20 Mar 20
Unum Therapeutics Announces Common Stock Purchase Agreement for up to $25
7:40am
8-K
EX-99.1
lnjtncp2
2 Mar 20
Unum Therapeutics Implements Strategic Restructuring to Prioritize Efforts on BOXR1030 for the Treatment of Solid Tumor Cancers
8:50am
8-K
EX-99.1
5kv46
29 Jan 20
Other Events
7:13am
8-K
EX-99.1
f8yrl3x9ka8 qhiokc
9 Dec 19
Unum Therapeutics Announces New Data at the American Society of Hematology (ASH) Annual Meeting
7:00am
8-K
EX-99.1
9xowp1m zcwl6cxi
12 Nov 19
Unum Therapeutics Reports Third Quarter 2019 Financial Results
4:36pm
8-K
EX-99.1
bm45zoi wn
5 Nov 19
Unum Therapeutics Presents Preclinical Data for BOXR1030 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
2:16pm
8-K
EX-99.1
bh9tcps6 o63hs2g2
4 Nov 19
Unum Therapeutics Announces Strategic Focus on DevelopingBest-in-Class
4:13pm
8-K
EX-99.1
kk6x5rv8ldyoagj3x lr
12 Aug 19
Unum Therapeutics Reports Second Quarter 2019 Financial Results
4:12pm